Search research articles
Contact Us
Filters
Showing results (291-300 of 905) with videos related to
Page
of 91
Sort By:
Vaccine
|
July 29, 2008
Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa
Shraddha Kumari, Mukesh Samant, Prashant Khare, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|
June 17, 2018
Screening for dysglycaemia using anthropometric indices in an adult population in Oman
Shyam Sundar Ganguly, Kamalesh Sarkar, Samir Al-Adawi, et al.
Indian Journal of Biochemistry & Biophysics
|
April 21, 2009
Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates
Goutam Mandal, Avijit Sarkar, Piu Saha, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2009
Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles
Maninder Minu, Ananda Thangadurai, Sharad Ramesh Wakode, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2009
Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment
Shyam Sundar, Neha Agrawal, Rakesh Arora, et al.
Plos One
|
February 1, 2012
Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters
Shraddha Kumari, Pragya Misra, Rati Tandon, et al.
Drug Design, Development and Therapy
|
September 13, 2014
Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
Shyam Lal Mudavath, Mahe Talat, Madhukar Rai, et al.
Scientific Reports
|
December 7, 2021
A rapid point of care CC16 kit for screening of occupational silica dust exposed workers for early detection of silicosis/silico-tuberculosis
Shyam Sundar Nandi, Upendra P Lambe, Kamalesh Sarkar, et al.
Journal of Infection and Public Health
|
February 10, 2022
Management of mild to moderate COVID-19 during the second wave in India: A non-evidence-based approach
Sunil Kumar Garg, Anupam Chauhan, Ramakant Sharma, et al.
Plos One
|
June 14, 2014
Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters
Rajendra K Baharia, Rati Tandon, Amogh A Sahasrabuddhe, et al.
Page
of 91
Search research articles
Search
Showing results (291-300 of 905) with videos related to
Sort By:
Page
of 91
Vaccine
|
July 29, 2008
Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa
Shraddha Kumari, Mukesh Samant, Prashant Khare, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|
June 17, 2018
Screening for dysglycaemia using anthropometric indices in an adult population in Oman
Shyam Sundar Ganguly, Kamalesh Sarkar, Samir Al-Adawi, et al.
Indian Journal of Biochemistry & Biophysics
|
April 21, 2009
Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates
Goutam Mandal, Avijit Sarkar, Piu Saha, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2009
Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles
Maninder Minu, Ananda Thangadurai, Sharad Ramesh Wakode, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2009
Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment
Shyam Sundar, Neha Agrawal, Rakesh Arora, et al.
Plos One
|
February 1, 2012
Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters
Shraddha Kumari, Pragya Misra, Rati Tandon, et al.
Drug Design, Development and Therapy
|
September 13, 2014
Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
Shyam Lal Mudavath, Mahe Talat, Madhukar Rai, et al.
Scientific Reports
|
December 7, 2021
A rapid point of care CC16 kit for screening of occupational silica dust exposed workers for early detection of silicosis/silico-tuberculosis
Shyam Sundar Nandi, Upendra P Lambe, Kamalesh Sarkar, et al.
Journal of Infection and Public Health
|
February 10, 2022
Management of mild to moderate COVID-19 during the second wave in India: A non-evidence-based approach
Sunil Kumar Garg, Anupam Chauhan, Ramakant Sharma, et al.
Plos One
|
June 14, 2014
Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters
Rajendra K Baharia, Rati Tandon, Amogh A Sahasrabuddhe, et al.
Page
of 91